Cargando…

New Challenges in Drug Allergy: the Resurgence of Excipients

PURPOSE OF REVIEW: Allergy to excipients is a cause of multidrug allergy and if it is not taken into account, it can lead to unexpected severe reactions. If an excipient allergy is suspected, an accurate examination followed by algorithms is very important for a correct diagnosis and to give patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Venturini Díaz, Mónica, Vidal Oribe, Irene, D’Elia Torrence, Diana, Hernández Alfonso, Pilar, Alarcón Gallardo, Eladia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308858/
https://www.ncbi.nlm.nih.gov/pubmed/35910462
http://dx.doi.org/10.1007/s40521-022-00313-6
_version_ 1784753037641777152
author Venturini Díaz, Mónica
Vidal Oribe, Irene
D’Elia Torrence, Diana
Hernández Alfonso, Pilar
Alarcón Gallardo, Eladia
author_facet Venturini Díaz, Mónica
Vidal Oribe, Irene
D’Elia Torrence, Diana
Hernández Alfonso, Pilar
Alarcón Gallardo, Eladia
author_sort Venturini Díaz, Mónica
collection PubMed
description PURPOSE OF REVIEW: Allergy to excipients is a cause of multidrug allergy and if it is not taken into account, it can lead to unexpected severe reactions. If an excipient allergy is suspected, an accurate examination followed by algorithms is very important for a correct diagnosis and to give patients detailed information in order to avoid future reactions. RECENT FINDINGS: In recent times, due to allergy COVID vaccine reactions, interest in excipients as polyethylene glycol derivatives (PEGs) has increased as a possible cause of drug and vaccine hypersensivity. In addition to PEGs many other excipients as gelatin, alpha-gal, protamine, benzalkonium chloride, and benzyl alcohol have been described as a cause of allergy to drugs and vaccines. For most excipients, the dilutions used for skin testing (ST) are not standardized and proper algorithms to reach a diagnosis are not available. SUMMARY: The purpose of this article is to review the excipients that may produce inmediate hypersensitivity drugs and vaccine reactions and update diagnostic procedures to reach an accurate diagnosis. We highlight the in vivo and in vitro diagnostic tests used in published reports and detail the dilution used for each excipient to perform ST in order to confirm this vital pathology and to prevent new reactions.
format Online
Article
Text
id pubmed-9308858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93088582022-07-25 New Challenges in Drug Allergy: the Resurgence of Excipients Venturini Díaz, Mónica Vidal Oribe, Irene D’Elia Torrence, Diana Hernández Alfonso, Pilar Alarcón Gallardo, Eladia Curr Treat Options Allergy Drug Allergy (C Mayorga, Section Editor) PURPOSE OF REVIEW: Allergy to excipients is a cause of multidrug allergy and if it is not taken into account, it can lead to unexpected severe reactions. If an excipient allergy is suspected, an accurate examination followed by algorithms is very important for a correct diagnosis and to give patients detailed information in order to avoid future reactions. RECENT FINDINGS: In recent times, due to allergy COVID vaccine reactions, interest in excipients as polyethylene glycol derivatives (PEGs) has increased as a possible cause of drug and vaccine hypersensivity. In addition to PEGs many other excipients as gelatin, alpha-gal, protamine, benzalkonium chloride, and benzyl alcohol have been described as a cause of allergy to drugs and vaccines. For most excipients, the dilutions used for skin testing (ST) are not standardized and proper algorithms to reach a diagnosis are not available. SUMMARY: The purpose of this article is to review the excipients that may produce inmediate hypersensitivity drugs and vaccine reactions and update diagnostic procedures to reach an accurate diagnosis. We highlight the in vivo and in vitro diagnostic tests used in published reports and detail the dilution used for each excipient to perform ST in order to confirm this vital pathology and to prevent new reactions. Springer International Publishing 2022-07-24 2022 /pmc/articles/PMC9308858/ /pubmed/35910462 http://dx.doi.org/10.1007/s40521-022-00313-6 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Drug Allergy (C Mayorga, Section Editor)
Venturini Díaz, Mónica
Vidal Oribe, Irene
D’Elia Torrence, Diana
Hernández Alfonso, Pilar
Alarcón Gallardo, Eladia
New Challenges in Drug Allergy: the Resurgence of Excipients
title New Challenges in Drug Allergy: the Resurgence of Excipients
title_full New Challenges in Drug Allergy: the Resurgence of Excipients
title_fullStr New Challenges in Drug Allergy: the Resurgence of Excipients
title_full_unstemmed New Challenges in Drug Allergy: the Resurgence of Excipients
title_short New Challenges in Drug Allergy: the Resurgence of Excipients
title_sort new challenges in drug allergy: the resurgence of excipients
topic Drug Allergy (C Mayorga, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308858/
https://www.ncbi.nlm.nih.gov/pubmed/35910462
http://dx.doi.org/10.1007/s40521-022-00313-6
work_keys_str_mv AT venturinidiazmonica newchallengesindrugallergytheresurgenceofexcipients
AT vidaloribeirene newchallengesindrugallergytheresurgenceofexcipients
AT deliatorrencediana newchallengesindrugallergytheresurgenceofexcipients
AT hernandezalfonsopilar newchallengesindrugallergytheresurgenceofexcipients
AT alarcongallardoeladia newchallengesindrugallergytheresurgenceofexcipients